FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1905-1906 June 13, 2002 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Perl, T. M. PubMed Citation

Infections at surgical sites remain an important cause of illness and death and substantially increase health care costs.¹ Prevention is thus important not only for the safety of patients, but also in terms of cost effectiveness. In this issue of the Journal, Perl and colleagues² report the results of a randomized trial that sought to prevent surgical-site infections due to Staphylococcus aureus. S. aureus is the most frequent cause of surgical-site infections and is more virulent than other frequent causes, such as coagulase-negative staphylococci and enterococci. S. aureus therefore accounts for a large proportion of the morbidity and mortality . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Carson, K. C., Bartlett, J. G., Tan, T.-J., Riley, T. V. (2007). In Vitro Susceptibility of Methicillin-Resistant Staphylococcus aureus and Methicillin-Susceptible Staphylococcus aureus to a New Antimicrobial, Copper Silicate. Antimicrob. Agents Chemother. 51: 4505-4507 [Abstract] [Full Text]  
• (2002). Does Prophylactic Mupirocin Reduce Postoperative S. Aureus Infections?. JWatch Infect. Diseases 2002: 10-10 [Full Text]  
• (2002). No Routine Role for Mupirocin Before Surgery. JWatch General 2002: 4-4 [Full Text]